Hyperactivity and Inattention Disorder. Attention-deficit hyperactivity disorders
Conditions
Interventions
Intervention 1: Intervention group1: Vardibel syrup+ routine Chemical drug (Methylphenidate) Vardibel syrup is m
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Years to 14 Years
Inclusion criteria
Inclusion criteria: Children 5-14 years old with attention deficit / hyperactivity disorder The child was treated with methylphenidate Lack of simultaneous use of other alternative and complementary therapies
Exclusion criteria
Exclusion criteria: mental retardation No psychiatric disorder (bipolar disorder type 1, psychosis, autism and any comorbid and using separate treatment). Chronic physical illness, including organic cerebral problems or seizures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of attention deficit / hyperactivity disorder based on the questionnaire score. Timepoint: The first day of receiving the drug (0), 4 and 8 weeks from the start of the drug. Method of measurement: Conners Scale (Home and School Version),CSI4,Temperment questionaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life and Side Effects of Nastaran and Pardihan Syrups. Timepoint: Outcome assessment at the beginning of the study, the fourth week and the eighth week, is done 3 times in total. Method of measurement: Conners , CSI4 and Temperment questionnaires. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHaide Golsorkhi
Iran University of Medical Sciences
Outcome results
None listed